Richard A. Miller Insider Profile

Richard A. Miller, Pres, CEO & Director, Director at Pharmacyclics, holds 626.93K shares in Pharmacyclics (Ticker: PCYC), holds 1.77M shares in Corvus Pharmaceuticals (Ticker: CRVS), holds ― shares in Bolt Biotherapeutics (Ticker: BOLT). Most recently, Richard A. Miller ― shares of Pharmacyclics on ― for an estimated value of ―.
Richard A. Miller

Richard A. Miller
Pharmacyclics (PCYC)
Pres, CEO & Director, Director

Ranked #5,370 out of 99,541 Corporate Insiders

Profitable Transactions

10 out of 21 Profitable Transactions

Average Return

Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

A breakdown of Richard A. Miller's holdings

Insider Roles

Corvus Pharmaceuticals
President & CEO, Director
Bolt Biotherapeutics
Roles that Richard A. Miller holds in companies

Most Profitable Insider Trade

Corvus Pharmaceuticals
Rating:Informative Buy
Date:Jun 06, 2022 - Jun 06, 2023
The most profitable trade made by Richard A. Miller

Richard A. Miller's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Corvus Pharmaceuticals
May 14, 2024
President & CEO, Director
Uninformative Sell
Bolt Biotherapeutics
List of latest transactions for each holding click on a transaction to see Richard A. Miller's performance on stock

Richard A. Miller insider profile FAQ

What is the percentage of profitable transactions made by Richard A. Miller?
The percentage of profitable transactions made by Richard A. Miller is 48%.
    What is the average return per transaction made by Richard A. Miller?
    The average return per transaction made by Richard A. Miller is 18.30%.
      What stocks does Richard A. Miller hold?
      Richard A. Miller holds: PCYC, CRVS, BOLT stocks.
        What was Richard A. Miller’s latest transaction?
        Richard A. Miller latest transaction was an Uninformative Buy of ―.
          What was Richard A. Miller's most profitable transaction?
          Richard A. Miller’s most profitable transaction was an Informative Buy of CRVS stock on June 6, 2022. The return on the trade was 238.20%.
            What is Richard A. Miller's role in Pharmacyclics?
            Richard A. Miller's role in Pharmacyclics is Pres, CEO & Director, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.